Studies have shown trends toward improved outcome for locally advanced (unresectable) non-small cell lung cancer with the combination of optimal chemotherapy with standard radiation therapy. Taxol has shown signigicant activity as a single agent and synergy has been demonstrated between Taxol and radiation therapy. This study will assess the combination therapy with escalating doses of Taxol to assess toxicity of the combination.
Showing the most recent 10 out of 693 publications